An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

Press/Media

Period2 Oct 2018

Media coverage

1

Media coverage

  • TitleAn Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
    Media name/outletClinical Trials.gov
    Country/TerritoryUnited States
    Date2/10/18
    PersonsLawrence Cohen
View all 1
View less